Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ Key Points ++ Disease summary: Dilated cardiomyopathy (DCM) is characterized by left ventricular (LV) enlargement and systolic dysfunction. The prevalence of DCM is 1 in 2700, however, this is undoubtedly an underestimate. Histologic findings include myocyte hypertrophy, myocyte loss, and interstitial fibrosis. Approximately 35% of DCM cases are deemed idiopathic dilated cardiomyopathy (IDC) after detectable causes have been excluded (Fig. 24-1). 20% to 50% of IDC may be found in one or more family members, and if so, is termed familial dilated cardiomyopathy (FDC). Of these cases, approximately 20% to 25% have identifiable genetic mutations correlating with disease phenotype. ++ Hereditary basis: A majority of heritable DCM is nonsyndromic disease isolated to the heart and can be divided into two subsets: FDC, as defined above. IDC with a known genetic mutation but no known familial penetrance. Because of the availability of genetic testing, some patients with IDC are sent for testing and have positive results. Less commonly, heritable DCM can occur as part of a genetic syndrome; causes from autosomal and X-linked genes are shown (Table 24-1). Differential diagnosis: Differential includes all detectable causes of dilated cardiomyopathy: ischemic, congenital, primary valvular, toxin-induced, metabolic abnormalities, and infectious (Fig. 24-1). Table Graphic Jump LocationTable 24-1Syndromic Dilated CardiomyopathyView Table||Download (.pdf) Table 24-1 Syndromic Dilated Cardiomyopathy Syndrome Gene Symbol Gene Product Inheritance Patterna Additional Clinical Features Emery-Dreifuss muscular dystrophy types 2 and 3 (EDMD2 and EDMD3), limb girdle muscular dystrophy (LGMD1B) LMNA Lamin A/C EMD 2: AD EMD3: AR LGMD1B: AD Joint contractures (more severe in EDMD), arrhythmias, childhood muscle weakness (shoulder or hip girdle in LGMD1B) Hemochromatosis HFE Hereditary hemochromatosis AR Cirrhosis, diabetes, hypermelanotic pigmentation, increased serum iron and ferritin Laing distal myopathy MYH7 Beta-myosin heavy chain AD Childhood-onset weakness of ankles and great toes, then finger extensors. Neck flexors and facial weakness Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) DMD Dystrophin XL DMD: males: elevated CK, childhood muscle weakness, wheelchair bound by age 12, DCM after age 18; BMD: elevated CK, skeletal muscle weakness in 20s or lager; females can be affected with milder phenotype or DCM alone Barth syndrome TAZ/G4.5 Tafazzin XL Growth retardation, intermittent lactic academia, granulocytopenia, recurrent infections aAD, autosomal dominant; AR, autosomal recessive; XL, X-linked; CK, creatine kinase. Adapted from Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail. 2009;2:253-261. +++ Diagnostic Criteria and Clinical Characteristics +++ Diagnostic Criteria, DCM ++ Fractional shortening less than 25% (>2 SD) and/or ejection fraction less than 45% (>2 SD) LV enlargement +++ Diagnostic Criteria Compatible With IDC ++ DCM with no evidence of a detectable cause (Fig. 24-1). ++ Figure 24-1 Diagnostic Algorithm for Dilated Cardiomyopathy (DCM). Graphic Jump ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.